GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ME Therapeutics Holding Inc (XCNQ:METX) » Definitions » Sale Of Investment

ME Therapeutics Holding (XCNQ:METX) Sale Of Investment : C$0.00 Mil (TTM As of Feb. 2024)


View and export this data going back to 2023. Start your Free Trial

What is ME Therapeutics Holding Sale Of Investment?

ME Therapeutics Holding's sale of investment for the three months ended in Feb. 2024 was C$0.00 Mil. It means ME Therapeutics Holding gained C$0.00 Mil from selling investments. ME Therapeutics Holding's sale of investment for the trailing twelve months (TTM) ended in Feb. 2024 was C$0.00 Mil.

Compared with last quarter (C$0.00 Mil in Nov. 2023 ), ME Therapeutics Holding gained the same money from selling investments in Feb. 2024 (C$0.00 Mil).


ME Therapeutics Holding Sale Of Investment Historical Data

The historical data trend for ME Therapeutics Holding's Sale Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ME Therapeutics Holding Sale Of Investment Chart

ME Therapeutics Holding Annual Data
Trend Aug22 Aug23
Sale Of Investment
- -

ME Therapeutics Holding Quarterly Data
Aug22 Dec22 May23 Aug23 Nov23 Feb24
Sale Of Investment Get a 7-Day Free Trial - - - - -

ME Therapeutics Holding Sale Of Investment Calculation

Sale of Investments represents cash inflow on the sale of investments in securities.

Sale Of Investment for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ME Therapeutics Holding Sale Of Investment Related Terms

Thank you for viewing the detailed overview of ME Therapeutics Holding's Sale Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.


ME Therapeutics Holding (XCNQ:METX) Business Description

Comparable Companies
Traded in Other Exchanges
Address
177 Robson Street, Vancouver, BC, CAN, V6B 0N3
ME Therapeutics Holding Inc operates its business through ME Therapeutics. It is a preclinical-stage biotechnology company working on novel cancer-fighting drugs in the field of Immuno-Oncology (IO). It is developing preclinical data for its myeloid-targeted candidate assets using validated cancer models.

ME Therapeutics Holding (XCNQ:METX) Headlines

No Headlines